Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. - Wikidata - awgldk - TriplyDB

Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.

Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.

http://www.wikidata.org/entity/Q45017009

about

Brain tumors Pseudoprogression in high-grade glioma.Invited review--neuroimaging response assessment criteria for brain tumors in veterinary patients Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.Post-treatment imaging changes in primary brain tumors.Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.Imaging in neurooncology [(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities.Diagnostics of cerebral gliomas with radiolabeled amino acids.PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET.Diagnosis of Brain Tumors Using Amino Acid Transport PET Imaging with 18F-fluciclovine: A Comparative Study with L-methyl-11C-methionine PET Imaging.Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice.Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.Molecular imaging of gliomas with PET: opportunities and limitations.Radiation necrosis following treatment of high grade glioma--a review of the literature and current understanding.Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma.Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression.A preliminary quantitative proteomic analysis of glioblastoma pseudoprogression FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan.Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.Consequences of additional use of contrast-enhanced (18)F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer.Positron emission tomography: clinical applications in oncology. Part 2.NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies Magnetic resonance spectroscopic study of radiogenic changes after radiosurgery of cerebral arteriovenous malformations with implications for the differential diagnosis of radionecrosis.Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinoma Diagnostic Value of 11C-Methionine (MET) and 18F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis Perfusion and diffusion MRI combined with ¹¹C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas.Methodology for quantitative rapid multi-tracer PET tumor characterizations A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis†.An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using 18F-FDG-PET and 11C-methionine PET.Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats.Clinical Utility of Positron Emission Tomography in Patients with Malignant Glioma.A comparison study of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography-computed tomography scans in evaluation of patients with recurrent brain tumors.Paediatric nuclear medicine imaging.

P2860

Q24605136-85AA3507-33B3-4C1E-8EA3-733EFF11B8E6 Q30578798-59240189-BEC5-4B7F-B5D8-09D4273487AF Q30692995-31D5635F-728B-43CB-AAB1-302553C24610 Q30811922-D4AF0F21-01A5-4BCA-8DB9-3EDB08CD0E8F Q30835236-4440AA9C-5B15-4B40-9942-1818767BE6D1 Q30907831-C7F9813B-6AC0-421A-9071-D1B25280A6FC Q30989939-19BC7EB1-E7EE-45CC-9CC1-47D7727FA2E3 Q33395877-B188C661-F868-4A6E-BE23-D2FCB38E7955 Q33432870-6DC1FB54-FEC4-4520-AA02-17C1F5E8A55B Q33487194-741051B1-7ACD-4058-A06D-43694E8B1037 Q33578187-4D827B89-B1A7-4BA3-9FF0-D5D196185147 Q33746805-80856B1A-7A17-48E4-B09A-E6BF3E968B75 Q33830251-81A1E722-6059-4F93-818C-D8153B205C1D Q33862844-89476E6B-DB58-4C57-9562-9CA33A4D1C7D Q33894461-07BBD626-7548-418B-BC8F-25B12F43C58E Q33961188-A8A67FCF-12EE-43AD-AD67-3495197D0DDA Q34087196-3527BB75-149B-43D1-837F-109634CD4D51 Q34193723-D5823B28-71E1-4131-BE25-AD775A180DDD Q35103504-F8B13ECE-15D5-4502-90CF-F206B1779FF1 Q35368468-F1B4E381-D2C5-4647-86D8-43129880029E Q35914501-EBF8221B-DE8A-437A-A08D-5939D08201EE Q35943921-FA551B72-DFB3-4647-9765-97F91525421D Q36107374-86B05731-89F9-42C4-93F0-150929AF632F Q36112565-8C1BC7E0-5E6B-4C55-85C5-1226B54211DB Q36235666-5C1B464E-C620-463C-A507-CBEEED8F24AB Q36448703-00D387D6-FD15-425B-A295-BF547301139D Q36539340-CCE08C77-3F4A-4B50-B4A4-D1D3477ABFB6 Q36753743-C9B4E9B3-9E51-4C9A-A613-0E8D2F0532BE Q36924872-19AF3AE8-9050-4713-AC34-A1614B1176DB Q37016981-07E65DCC-D5C4-4D91-B156-09FFB8FD9952 Q37092483-2DC74F43-7616-4760-B72A-D38721A73422 Q37342653-2E663E95-29C3-47FE-879A-B5F9C9E0937B Q37400326-EE5E8375-0E68-42E8-9E51-2CFC8E66C45B Q37703206-6934833D-6675-4BDF-98D2-673635353DD9 Q38074638-D0D21187-57EC-4365-ABE9-4560198C4781 Q38815396-DE3402E9-1612-432F-A730-8AC0EC93141A Q38902139-9D047963-F364-4448-A547-C3CA44AD6B6E Q39274022-07D4E8CF-AF2A-4AC4-B04A-9DD0CC285FDA Q39724277-A49F1AE0-CBAB-45A2-BFAB-35E7686AE200 Q40045765-474ECE4B-163C-4B7A-AD55-1C05DB4C37CE

P2860

Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.

http://www.wikidata.org/entity/Q45017009

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Direct comparison of 18F-FDG a ...... iability and prognostic value.

@en

Direct comparison of 18F-FDG a ...... iability and prognostic value.

@nl

type

label

Direct comparison of 18F-FDG a ...... iability and prognostic value.

@en

Direct comparison of 18F-FDG a ...... iability and prognostic value.

@nl

prefLabel

Direct comparison of 18F-FDG a ...... iability and prognostic value.

@en

Direct comparison of 18F-FDG a ...... iability and prognostic value.

@nl

P1433

Q45017009-F7FFDEEC-9CED-41BE-8250-7FB2483CE45A

P1476

Q45017009-2D48E201-B045-44EA-9032-7C46F0057EAB

P2093

Q45017009-1E71EDE9-B666-4001-A1F6-42356B76BDFC

Q45017009-524FD5C2-1F9F-4F11-8EB6-FBCA59122455

Q45017009-57E62AFA-C07D-4E29-AE34-9C0349E1A59D

Q45017009-59C37D39-2652-4A56-B914-1467C76AED6B

Q45017009-7F6A467D-5350-4017-8CCC-6E9DEE913100

Q45017009-A8E090C1-E905-479A-B6C4-A6BC0730301F

Q45017009-A992BBE9-2F89-4588-AC90-700D06CB0025

Q45017009-C1BD759B-8A14-481E-BF65-521CCE404A1D

P2860

Q45017009-438D31B6-E1B7-472F-BB53-FC54E1012B20

Q45017009-6E7D5250-D607-4498-AAF2-840D23EA2D39

Q45017009-7CC3A0A7-84D4-4199-B0DF-AAAB3ED56B61

Q45017009-92285984-58D7-45E5-B5EF-688573E5775F

P2888

Q45017009-34BEA0F2-3B05-4981-8C3D-187B85722D4A

P304

Q45017009-02A0386A-E6B5-40DC-9380-268CC17D65E0

P31

Q45017009-3E99E16D-514A-4A06-8E46-136B812046DA

P356

Q45017009-ABE8795D-F152-41DE-AF44-20BF716597DD

P433

Q45017009-C3BD3E65-8051-4847-98E4-010BF28D6D0F

P478

Q45017009-25C0759B-7BDB-4038-97F4-513F778BC73F

P577

Q45017009-223DF060-76D5-4446-A4F7-DA88279351B2

P6179

Q45017009-8DF5602B-3F9A-4CAB-8F79-F65D0C621FBA

P698

Q45017009-11BD6F9A-6F1C-46D9-B58A-B77D6B57DDBE

P356

S00259-004-1564-3

P1433

European Journal of Nuclear Medicine and Molecular Imaging

P1476

Direct comparison of 18F-FDG a ...... iability and prognostic value.

@en

P2093

Frank Van Calenbergh

http://www.w3.org/2001/XMLSchema#string

Guy Bormans

http://www.w3.org/2001/XMLSchema#string

Johan Menten

http://www.w3.org/2001/XMLSchema#string

Koen Van Laere

http://www.w3.org/2001/XMLSchema#string

Luc Mortelmans

http://www.w3.org/2001/XMLSchema#string

Patrick Flamen

http://www.w3.org/2001/XMLSchema#string

Sarah Ceyssens

http://www.w3.org/2001/XMLSchema#string

Tjibbe de Groot

http://www.w3.org/2001/XMLSchema#string

P2860

Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies.

Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.

Indications for differential diagnosis of nontumor central nervous system diseases from tumors. A positron emission tomography study.

The prognostic impact of prior low grade histology in patients with anaplastic gliomas: a case-control study.

P2888

s00259-004-1564-3

P304

39-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-004-1564-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043340294

http://www.w3.org/2001/XMLSchema#string

P698

15309329

http://www.w3.org/2001/XMLSchema#string